INTERNATIONAL FLAVORS & FRAGRANCES INC IFF

International Flavors & Fragrances moved the daily file from routine earnings watch to portfolio surgery with its June 1, 2026 8-K. That filing says IFF issued a May 29 press release announcing entry into the Transaction Agreement, and the release says the Food Ingredients business to be divested generated nearly $3.1 billion in 2025 annual sales and about $430 million of EBITDA. This is the central evidence point: IFF is not trimming a stray label, it is preparing to move a sizeable operating business.

IFF is an equity tied to the business of flavours, fragrances and related ingredients, so the report has to stay close to product reality. The supplied source rail does not give a new product launch or approval. It gives a transaction involving Food Ingredients, the company’s own earnings and filing record, inventory, research and development expense, capital expenditure and litigation disclosure. That is enough to show a company being judged through products, customers, formulations, factories and legal exposure rather than through a loose market mood.

The latest supplied filed financials are from the 10-Q for the period ending March 31, 2026. IFF reported revenue from contracts with customers of $2.74 billion, operating income of $273.0 million, net income attributable to parent of $169.0 million and diluted EPS of $0.66. Assets were $25.14 billion, stockholders’ equity attributable to parent was $14.12 billion, cash and cash equivalents were $562.0 million, operating cash flow was $257.0 million, payments to acquire property, plant and equipment were $165.0 million, research and development expense was $166.0 million and inventory, net, was $2.25 billion.

The supplied rail does not include a chart route, candle data, valuation multiple or market price level, so this report cannot claim support, resistance, moving averages or any visible trading pattern. The market mechanism shown by the evidence is instead a filing mechanism: a March quarter earnings base, a June transaction announcement, Form 4 filings on May 6 and June 2, and SEC company pages that anchor the public record. The daily question is therefore not where a chart line sits, but how the transaction, cash, inventory, R&D spend and legal disclosures change the way the equity story is read.

The May 29 press release also says the company expects full year 2026 sales in the range of $10.5 billion to $10.8 billion. It says IFF continues to expect comparable currency neutral sales growth between 1% and 4%, and comparable currency neutral adjusted operating EBITDA growth of 3% to 8%. The same transaction rail carries a forward-looking warning in the June 1 8-K: management’s present views depend on expectations, assumptions, estimates and projections, are subject to change, and involve uncertainties that could cause actual results to differ materially.

The risk rail is not empty. The March 31, 2026 10-Q says an additional class action complaint was filed on January 27, 2026 in the District of New Jersey on behalf of purchasers in the United States of consumer goods containing fragrance products purchased outside the United States. The same filing says the decrease in cost of goods sold was primarily driven by divestitures, with an impact of about $202 million, offset in part by volume increases in sales. That mix matters because the cleaner portfolio story is being built while the company is still managing volume, cost base, inventory and litigation detail.